Medication Safety and Quality Assurance
High-alert thinking
ISMP designates high-alert medications-anticoagulants, insulin, opioids, concentrated electrolytes, chemotherapy, and neuromuscular blockers-as those with heightened risk of harmful error. Use Tall Man lettering for look-alike/sound-alike pairs such as hydrOXYzine and hydrALAZINE, or glipiZIDE and glyBURIDE, and require an independent double check for high-alert doses. The five rights-right patient, drug, dose, route, and time-are a starting point; add documentation, reason, and the patient's right to refuse.
Error vocabulary
A medication error is a preventable failure in the process. An adverse drug event is harm from a drug, whether or not preventable. An adverse drug reaction is harm at a normal dose. A near miss was caught before harm occurred. All are reportable, because reporting drives system fixes.
Culture and tools
Just culture separates honest mistakes from reckless behavior and encourages reporting. Root cause analysis asks why the system allowed the error. Barcode scanning, smart pumps, automated dispensing cabinets, standardized concentrations, and Tall Man labels are system defenses. The do-not-use list bans U, IU, QD, QOD, MS, MSO4, and trailing zeros; write 5 mg rather than 5.0 mg, and 0.5 mg rather than .5 mg. Report serious adverse events to FDA MedWatch and errors to ISMP MERP.
Traps
- Assuming an error must cause harm to be reportable.
- Blaming an individual instead of examining the system.
- Confusing an adverse drug reaction with an error; response and reporting differ.
- Overlooking look-alike packaging because the prescription looked right.
Worked example
An order reads insulin 10 U. You flag the banned abbreviation, clarify to 10 units before the product leaves the pharmacy, and document the near miss even though no patient was harmed.
Rule of thumb: report the error and fix the system, not the person.